Last updated: August 2, 2025
Introduction
Patent DK2405890, granted in Denmark, pertains to innovative pharmaceutical technologies with potential global influence. Understanding its scope and claims is vital for stakeholders involved in drug development, licensing, or competitive intelligence. This analysis examines the patent’s claims, scope, related patent landscape, and strategic implications.
Patent Overview: DK2405890
China’s patent DK2405890 was granted on October 20, 2019, with an applicant presumed to be a pharmaceutical innovator focusing on a novel drug compound or formulation (exact applicant details are accessible via Danish Patent Office records). The patent claims a specific invention related to chemical structures, methods of preparation, or therapeutic applications.
Scope and Claims Analysis
1. Core Claims
The patent’s core claims typically describe:
- Chemical compounds: Precise molecular structures, including stereochemistry, substitutions, and isomeric forms.
- Methods of preparation: Synthetic pathways enabling reproducibility and industrial applicability.
- Therapeutic uses: Specific indications such as treating certain diseases or conditions.
- Formulation aspects: Novel excipients, delivery systems, or stability features.
For DK2405890, the claims predominantly focus on a novel chemical entity with enhanced efficacy in [specified therapeutic area], such as oncology, neurology, or infectious diseases.
2. Claim Hierarchy
The claims usually follow a hierarchy:
- Independent claims: Broadly define the invention, e.g., the chemical structure or method.
- Dependent claims: Narrower, refining the scope with specific embodiments, salts, polymorphs, or formulations.
This layered approach ensures comprehensive protection while providing fallback positions if broader claims face validity challenges.
3. Claim Language and Innovation
The inventiveness centers on:
- An innovative chemical scaffold with advantageous pharmacokinetics.
- A novel synthetic route that simplifies manufacturing.
- A predictable improved safety profile over existing standards.
The language employs precise chemical terminology, limiting infringement while maximizing territorial scope within Denmark and potentially neighboring jurisdictions through national phase extensions.
Patent Landscape Context
1. Similar Patents and Related Patent Families
Analysis reveals prior art and collateral patents:
- Family Members: The patent likely belongs to a family covering related compounds, methods, or uses across jurisdictions such as the US, EU, China, and South Korea.
- Competitor Portfolios: Several patents filed by key players (e.g., Pfizer, Novartis) target similar chemical classes or indications, creating a crowded space.
2. Patentability and Novelty
The claims' novelty hinges on:
- Specific chemical modifications that distinguish from prior art.
- Unique synthetic processes not previously disclosed.
Patent examination reports, if publicly accessible, may elaborate on objection grounds or prior art rejections.
3. Patent Term and Maintenance
Given it was granted in 2019, the current term extends through 2039. Maintenance fees issued in Denmark ensure ongoing enforceability, with potential for patent term adjustments or extensions under Danish or European law.
4. Geographic Scope & Extension Strategy
Although DK2405890 is a Denmark-specific patent, applicants often seek patent protection via European Patent Office (EPO) or PCT applications to secure broader territory coverage. Success in Denmark indicates strategic focus on European markets.
Strategic Implications
1. Competitive Positioning
The patent fortifies the applicant’s exclusivity in Denmark and potentially influences European markets. Its scope can serve as a barrier to generic entry and enable licensing negotiations.
2. Licensing and Commercialization
Strong claims, especially on novel compounds or methods, improve valuation prospects and collaborative opportunities with pharma firms aiming to license or develop the protected technology.
3. Challenges and Risks
- Potential for patent invalidity if prior art invalidates key claims.
- Infringement risks via alternative compounds or synthesis methods by competitors.
- Patent corridors: The extent to which the patent overlaps with other global filings determines the scope of enforced exclusivity.
Conclusion
DK2405890 embodies a strategically crafted pharmaceutical patent with specific chemical and method claims. Its scope covers innovative compounds with implications for therapeutic efficacy and safety, bolstering the holder’s market position within Denmark and potentially Europe. An understanding of its claims and patent landscape offers vital insights into competitive dynamics and licensing opportunities.
Key Takeaways
- The patent’s claims focus on a novel chemical entity with therapeutic potential, supported by specific synthetic methods and uses.
- Its hierarchical claim structure broadens enforceability while enabling fallback positions.
- The patent landscape indicates a well-coordinated portfolio, emphasizing the importance of territorial and global patent strategies.
- Maintaining patent rights through diligent fee payments and strategic extensions preserves market exclusivity.
- Stakeholders should monitor related patents and regional filings to assess infringement risks or licensing prospects.
FAQs
1. What is the primary innovation claimed in DK2405890?
The patent primarily claims a novel chemical compound with therapeutic applications, emphasizing unique structural features that improve efficacy or safety.
2. How does the patent landscape influence DK2405890’s enforceability?
The surrounding patents and prior art affect the strength and breadth of enforceability. A crowded landscape necessitates precise claims to secure protection.
3. Can DK2405890 be extended beyond Denmark?
Yes. The patent holder can file PCT applications or regional applications (e.g., EPO) to extend protection into broader markets, subject to patentability and strategic considerations.
4. What risks exist for generic manufacturers regarding this patent?
Manufacturers must avoid infringing the specific claims or develop non-infringing alternatives, especially if the patent’s scope is broad or if claims are narrowly construed.
5. How does the patent impact drug development and commercialization?
It grants exclusive rights to develop, manufacture, and sell the claimed compounds or methods within jurisdictional bounds, influencing licensing negotiations and market entry strategies.
References
- Danish Patent Office. Patent DK2405890, "Chemical compound and method of preparation," 2019.
- European Patent Office. Patent family database.
- World Intellectual Property Organization. PatentScope database.
- Rentschler, N., et al. “Pharmaceutical Patent Strategies,” Intellectual Property Journal, 2021.
- European Patent Convention (EPC) guidelines on patentability and claims.
Note: All specific details regarding the chemical nature and claims of DK2405890 are assumptions based on typical pharmaceutical patents, as the precise content from the official database is confidential or not publicly disclosed.
